NEONATAL GRAVES
1. Source:Nelson Textbook of Pediatrics 21e
What is neonatal
graves disease?
·
The transplacental transfer of TRSAbs from mother to
fetus results in Graves diseases in neonates.
2.
What are the
conditions of such illness?
·
Maternal untreated Graves
·
Mother treated with radioiodine and surgery can
develop
·
Mother treated for Graves with ATDS
·
Sometimes neonates of mother’s with Hashimotos
thyroiditis can develop Graves disease.
3.
What is the
presentation of neonatal thyrotoxicosis in neonate born to mother receiving ATDs?
·
They present after 3-7 days after the ATDs are metabolized
in newborn.
·
Sometimes after some weeks if TRBAbs are also present.
4.
Does neonatal
thyrotoxicosis occur in all neonates of Graves disease mother?
No. Only 2% DEVELOP.
Some predisposing factors are:
·
Elevated serum titers of
TRSAb (more than 3 times the upper limit of normal) or
·
History
of a prior child with neonatal thyroid dysfunction.
5.
How and when should be monitor the
fetus dueing intrapartum period?
In 3rd trimester and fetal tachycardia and goiter should be
evaluated.
6. Neonatal Graves disease
typically remits spontaneously within 6-12 wk but
can persist longer, depending on the titer and rate of clearance of the
TRSAbs.(and TRBAbs, if present).
7. Rarely, classic neonatal
Graves disease may not remit but persist for several yr or longer. These
children typically have a family history of Graves disease. In these infants,
the transfer of maternal TRSAbs exacerbates
the
infantile onset of autonomous Graves disease.
8.
How do the new born present?
·
LBW
and IUGR
·
prematurity
·
Goiter may be
present
·
stare,
·
periorbital edema,
·
retraction of the
eyelids,
·
hyperthermia,
·
irritability,
·
diarrhea,
·
feeding difficulties,
·
tachycardia, heart
failure, hypertension,
·
hepatomegaly, splenomegaly,
cholestasis, jaundice,
·
Thrombocytopenia, and
·
hyperviscosity
9.
LAB IX
·
Low
TSH and high total and free thyroid hormones.
·
TRSAbs are markedly elevated
at birth and typically resolve within 3 mo of life.
If symptoms and signs are not immediately recognized and treated,
cardiac failure and death can occur.
Craniosynostosis and developmental delay can be permanent sequelae
of the hyperthyroidism
10. How do we treat?
·
Methimazole (0.5-1.0
mg/kg/24 hr given every 12 hr)
·
Oral or intravenous
administration of a nonselective β- adrenergic blocker such as propranolol to
decreases sympathetic hyperactivity.
11. How do we treat refractory cases?
In refractory cases,
Lugol solution or potassium iodide (1-2 drops per day) can be added.
The first dose of iodide
should be given at least 1 hr after the 1st dose
of ATD to prevent the iodide from being used for further
thyroid hormone
synthesis.
If thyrotoxicosis is severe and
progresses to heart failure, parenteral
fluid therapy, corticosteroids,
and digitalization may be indicated.
Once
serum thyroid hormone levels begin to decrease, antithyroid medications should
be gradually tapered to keep the infant euthyroid.
12. In most of the cases neonatal thyrotoxicosis remits by 3 months of age
but in few cases it may result in permanent hyperthyroidism.
13.Usually such cases have family H/o hyperthyroidism.
14. TSHR gene mutation can cause neonatal Graves disease.
15. How does
resistance to thyroid hormone present?
·
They can present
with hypo or hyperthyroidism.
·
They are often
associated with ADHD in children.
·
LAB
Normal or elevated TSH
High T3 and T4
·
NO SPECIFIC
TREATMENT
Comments
Post a Comment